Back to Search
Start Over
Desensitization in Iron Product Allergy.
- Source :
-
Acta haematologica [Acta Haematol] 2020; Vol. 143 (5), pp. 496-499. Date of Electronic Publication: 2020 Mar 17. - Publication Year :
- 2020
-
Abstract
- Iron deficiency is the main cause of anemia in both sexes, with women being more commonly affected. Iron therapy is currently considered an effective and safe remedy to replenish the iron storages. Iron can be administrated both orally and intravenously. In particular, intravenous (IV) iron therapy is widely used when oral iron preparations are either not tolerated or ineffective. Indeed, IV iron improves iron stores more rapidly. Two main immunological responses have been described for iron hypersensitivity reactions (HSRs): IgE-mediated allergy and complement activation-related pseudo-allergy. Here, we report 3 cases of adult patients with iron allergy, who were successfully treated with two different desensitization procedures, respectively. Analysis of these cases demonstrates that, in the presence of HSRs to iron products, desensitization is an effective and safe procedure that prevents treatment discontinuation and hence allows therapeutic target achievement.<br /> (© 2020 S. Karger AG, Basel.)
- Subjects :
- Adult
Anemia, Iron-Deficiency drug therapy
Chlorpheniramine therapeutic use
Dexamethasone therapeutic use
Female
Ferric Compounds therapeutic use
Hematinics therapeutic use
Humans
Hypersensitivity etiology
Iron therapeutic use
Maltose analogs & derivatives
Maltose therapeutic use
Middle Aged
Skin Tests
Anemia, Iron-Deficiency diagnosis
Hypersensitivity diagnosis
Iron adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1421-9662
- Volume :
- 143
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Acta haematologica
- Publication Type :
- Academic Journal
- Accession number :
- 32182610
- Full Text :
- https://doi.org/10.1159/000503768